# DEXTROAMPHETAMINE SULFATE
> **ANDA205077** · Abbreviated New Drug Application (Generic) · Sponsor: STRIDES PHARMA · Approved 2019-06-21
## Drug
- **FDA Application Number:** ANDA205077
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DEXTROAMPHETAMINE SULFATE
- **Generic name:** Dextroamphetamine Sulfate
- **Active ingredients:** DEXTROAMPHETAMINE SULFATE
- **Dosage form:** CAPSULE, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** STRIDES PHARMA
- **First approval:** 2019-06-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205077)
---
*AI Analytics · CC0 1.0*